On the public citation graph

Evaluation of Safety and Immunogenicity of an Adjuvanted, TH-1 Skewed, Whole Virion Inactivated SARS-CoV-2 Vaccine - BBV152

https://doi.org/10.1101/2020.09.09.285445
0 signed · 58 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1007/978-3-662-45024-6_2openalex-snapshot
Inactivated Viral Vaccines
inferredcites →https://doi.org/10.1016/0304-3894(92)87011-4openalex-snapshot
Lowry's handbook of right-to-know emergency planning
inferredcites →https://doi.org/10.1016/j.cell.2020.05.015openalex-snapshot
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
inferredcites →https://doi.org/10.1016/j.cell.2020.06.008openalex-snapshot
Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2
inferredcites →https://doi.org/10.1016/j.chom.2020.04.021openalex-snapshot
The Challenges of Vaccine Development against a New Virus during a Pandemic
inferredcites →https://doi.org/10.1016/j.heliyon.2020.e04658openalex-snapshot
Integrative analyses of SARS-CoV-2 genomes from different geographical locations reveal unique features potentially consequential to host-virus interaction, pathogenesis and clues for novel therapies
inferredcites →https://doi.org/10.1016/j.intimp.2020.106717openalex-snapshot
Potential adjuvants for the development of a SARS-CoV-2 vaccine based on experimental results from similar coronaviruses
inferredcites →https://doi.org/10.1016/j.vaccine.2010.03.064openalex-snapshot
Immunogenicity and safety study of Indirab: A Vero cell based chromatographically purified human rabies vaccine
inferredcites →https://doi.org/10.1016/s0140-6736(13)62630-6openalex-snapshot
Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: a randomised, double-blind, placebo-controlled trial
inferredcites →https://doi.org/10.1021/jm2010207openalex-snapshot
Toll-Like Receptor (TLR)-7 and -8 Modulatory Activities of Dimeric Imidazoquinolines
inferredcites →https://doi.org/10.1038/s41577-020-0323-4openalex-snapshot
COVID-19 vaccine design: the Janus face of immune enhancement
inferredcites →https://doi.org/10.1080/21645515.2014.1004026openalex-snapshot
Advances in aluminum hydroxide-based adjuvant research and its mechanism
inferredcites →https://doi.org/10.1093/infdis/jiaa234openalex-snapshot
Balancing Expediency and Scientific Rigor in Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Development
inferredcites →https://doi.org/10.1093/infdis/jiv023openalex-snapshot
A Japanese Encephalitis Vaccine From India Induces Durable and Cross-protective Immunity Against Temporally and Spatially Wide-ranging Global Field Strains
inferredcites →https://doi.org/10.1093/infdis/jiz672openalex-snapshot
Persistence of Immune Responses With an Inactivated Japanese Encephalitis Single-Dose Vaccine, JENVAC and Interchangeability With a Live-Attenuated Vaccine
inferredcites →https://doi.org/10.1111/j.1365-3083.2005.01666.xopenalex-snapshot
Two Doses of Parenterally Administered Split Influenza Virus Vaccine Elicited High Serum IgG Concentrations which Effectively Limited Viral Shedding upon Challenge in Mice
inferredcites →https://doi.org/10.1126/science.abb8923openalex-snapshot
Rapid COVID-19 vaccine development
inferredcites →https://doi.org/10.1126/science.abc1932openalex-snapshot
Development of an inactivated vaccine candidate for SARS-CoV-2
inferredcites →https://doi.org/10.1126/sciimmunol.abd2071openalex-snapshot
Phenotype and kinetics of SARS-CoV-2–specific T cells in COVID-19 patients with acute respiratory distress syndrome
inferredcites →https://doi.org/10.1128/iai.00742-19openalex-snapshot
Critical Role of B Cells in Toll-Like Receptor 7-Mediated Protection against Listeria monocytogenes Infection
inferredcites →https://doi.org/10.1128/jvi.00983-14openalex-snapshot
Effects of Toll-Like Receptor Stimulation on Eosinophilic Infiltration in Lungs of BALB/c Mice Immunized with UV-Inactivated Severe Acute Respiratory Syndrome-Related Coronavirus Vaccine
inferredcites →https://doi.org/10.1146/annurev-immunol-042617-053214openalex-snapshot
Tissue-Resident T Cells and Other Resident Leukocytes
inferredcites →https://doi.org/10.1177/0192623319875085openalex-snapshot
Scientific and Regulatory Policy Committee Points to Consider*: Approaches to the Conduct and Interpretation of Vaccine Safety Studies for Clinical and Anatomic Pathologists
inferredcites →https://doi.org/10.3389/fimmu.2019.00566openalex-snapshot
Role of Type I Interferon (IFN) in the Respiratory Syncytial Virus (RSV) Immune Response and Disease Severity
inferredcites →https://doi.org/10.4049/jimmunol.1300244openalex-snapshot
B Cell–Intrinsic TLR7 Signaling Is Required for Optimal B Cell Responses during Chronic Viral Infection
inferredcites →https://doi.org/10.4103/ijmr.ijmr_1029_20openalex-snapshot
First isolation of SARS-CoV-2 from clinical samples in India
inferredcites →https://doi.org/10.4103/ijmr.ijmr_1058_20openalex-snapshot
Genomic analysis of SARS-CoV-2 strains among Indians returning from Italy, Iran & China, & Italian tourists in India
inferredcites →https://doi.org/10.4103/ijmr.ijmr_2382_20openalex-snapshot
Neutralizing antibody responses to SARS-CoV-2 in COVID-19 patients
inferredcites →https://doi.org/10.4103/ijmr.ijmr_663_20openalex-snapshot
Full-genome sequences of the first two SARS-CoV-2 viruses from India
inferredcites →https://doi.org/10.5501/wjv.v5.i2.85openalex-snapshot
Determination of 50% endpoint titer using a simple formula

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.1002/jcla.24418openalex-snapshot
An overview on inactivated and live‐attenuated SARS‐CoV‐2 vaccines
inferred← citeshttps://doi.org/10.1016/j.cytogfr.2020.11.001openalex-snapshot
SARS-CoV-2: Targeted managements and vaccine development
inferred← citeshttps://doi.org/10.1016/j.intimp.2021.107679openalex-snapshot
Essential considerations during vaccine design against COVID-19 and review of pioneering vaccine candidate platforms
inferred← citeshttps://doi.org/10.1016/j.isci.2021.102054openalex-snapshot
Immunogenicity and protective efficacy of BBV152, whole virion inactivated SARS- CoV-2 vaccine candidates in the Syrian hamster model
inferred← citeshttps://doi.org/10.1016/s1473-3099(20)30942-7openalex-snapshot
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial
inferred← citeshttps://doi.org/10.1016/s1473-3099(21)00070-0openalex-snapshot
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trial
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.4c00464openalex-snapshot
Structure–Activity Relationships toward the Identification of a High-Potency Selective Human Toll-like Receptor-7 Agonist
inferred← citeshttps://doi.org/10.1021/acs.molpharmaceut.0c01239openalex-snapshot
siRNA Therapeutics for the Therapy of COVID-19 and Other Coronaviruses
inferred← citeshttps://doi.org/10.1038/s41467-021-21639-wopenalex-snapshot
Immunogenicity and protective efficacy of inactivated SARS-CoV-2 vaccine candidate, BBV152 in rhesus macaques
inferred← citeshttps://doi.org/10.1080/22221751.2021.1971569openalex-snapshot
Long-term humoral immunogenicity, safety and protective efficacy of inactivated vaccine against COVID-19 (CoviVac) in preclinical studies
inferred← citeshttps://doi.org/10.1093/abt/tbab012openalex-snapshot
Safety and immunogenicity evaluation of inactivated whole-virus-SARS-COV-2 as emerging vaccine development in Egypt
inferred← citeshttps://doi.org/10.1101/2021.10.05.461434openalex-snapshot
Immunogenicity of SARS-CoV-2 trimetric spike protein associated to Poly(I:C) plus Alum
inferred← citeshttps://doi.org/10.1146/annurev-pharmtox-121120-012309openalex-snapshot
Experimental Models of SARS-CoV-2 Infection: Possible Platforms to Study COVID-19 Pathogenesis and Potential Treatments
inferred← citeshttps://doi.org/10.1208/s12249-021-01974-3openalex-snapshot
Next-Generation COVID-19 Vaccines Should Take Efficiency of Distribution into Consideration
inferred← citeshttps://doi.org/10.14429/dlsj.9.19191openalex-snapshot
Development of New Screening Methods for SARS CoV 2 and its Associated Developing Variations
inferred← citeshttps://doi.org/10.26434/chemrxiv-2024-20xp1openalex-snapshot
Structure−Activity Relationships Towards the Identification of High-Potency Selective Human Toll-Like Receptor-7 Agonist
inferred← citeshttps://doi.org/10.33425/2768-4598.1001openalex-snapshot
Preliminary Step towards COVID-19 Inactivated Vaccine Development in Egypt
inferred← citeshttps://doi.org/10.3389/fimmu.2021.641447openalex-snapshot
Comparative Immunomodulatory Evaluation of the Receptor Binding Domain of the SARS-CoV-2 Spike Protein; a Potential Vaccine Candidate Which Imparts Potent Humoral and Th1 Type Immune Response in a Mouse Model
inferred← citeshttps://doi.org/10.3389/fimmu.2022.836745openalex-snapshot
Safety and Efficacy of Combined Intramuscular/Intranasal RAZI-COV PARS Vaccine Candidate Against SARS-CoV-2: A Preclinical Study in Several Animal Models
inferred← citeshttps://doi.org/10.3389/fimmu.2022.863162openalex-snapshot
Inactivated vaccine Covaxin/BBV152: A systematic review
inferred← citeshttps://doi.org/10.3389/fimmu.2022.940715openalex-snapshot
A comprehensive review of BBV152 vaccine development, effectiveness, safety, challenges, and prospects
inferred← citeshttps://doi.org/10.3390/biomedicines9111740openalex-snapshot
Counting on COVID-19 Vaccine: Insights into the Current Strategies, Progress and Future Challenges
inferred← citeshttps://doi.org/10.3390/pathogens10070788openalex-snapshot
A Summary of the SARS-CoV-2 Vaccines and Technologies Available or under Development
inferred← citeshttps://doi.org/10.3390/v13030418openalex-snapshot
Target Product Profile Analysis of COVID-19 Vaccines in Phase III Clinical Trials and Beyond: An Early 2021 Perspective
inferred← citeshttps://doi.org/10.3390/vaccines11030607openalex-snapshot
Molecular Characterization and Selection of Indigenous SARS-CoV-2 Delta Variant for the Development of the First Inactivated SARS-CoV-2 Vaccine of Pakistan
inferred← citeshttps://doi.org/10.34172/apb.2022.045openalex-snapshot
Recent Update of COVID-19 Vaccines
inferred← citeshttps://doi.org/10.5501/wjv.v11.i1.40openalex-snapshot
Animal models for SARS-CoV-2 and SARS-CoV-1 pathogenesis, transmission and therapeutic evaluation
inferred← citeshttps://doi.org/10.59118/vqar2242openalex-snapshot
Comprehensive Review of the Initial 11 WHO Emergency Use Listed COVID-19 Vaccine Candidates: Mechanisms, Efficacy, and Comparative Attributes for Safety and Well-Being
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.